n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
New England Journal of Medicine2010Vol. 363(21), pp. 2015–2026
Citations Over TimeTop 1% of 2010 papers
Abstract
Low-dose supplementation with EPA-DHA or ALA did not significantly reduce the rate of major cardiovascular events among patients who had had a myocardial infarction and who were receiving state-of-the-art antihypertensive, antithrombotic, and lipid-modifying therapy. (Funded by the Netherlands Heart Foundation and others; ClinicalTrials.gov number, NCT00127452.).
Related Papers
- → Physiological Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)—A Review(2006)174 cited
- → Effects of Hormone Replacement Therapy on Circulating Docosahexaenoic Acid and Eicosapentaenoic Acid Levels in Postmenopausal Women.(2003)35 cited
- → Determination of eicosapentaenoic acid and docosahexaenoic acid contents and the oxidation level of fish oil supplements from Bahrain market(2023)1 cited
- Omega-3 fatty acids from fish and plants: same family different biological activity(2010)
- → Rapeseeds a Rich Source of Polyunsaturated Fatty Acids(2019)